One preliminary zinc supplementation trial in small-for-date infants reported as high as 67% reduction in the mortality rate with zinc supplementation between 2 and 9 months of age. We consider this effect as highly optimistic. Therefore, we calculated the required sample size based on more conservative estimates at various levels of expected reduction in mortality rate associated with zinc supplementation of LBW infants.